Preliminary criteria for classification of adult Still's disease
M Yamaguchi A Ohta T Tsunematsu R Kasukawa Y Mizushima H Kashiwagi 1992 Preliminary criteria for classification of adult Still's disease J Rheumatol 29 424 430
Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still's disease
DOI 10.1002/art.10620
M Iwamoto H Nara D Hirata S Minota N Nishimoto K Yoshizaki 2002 Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still's disease Arthritis Rheum 46 3388 3389 1:CAS:528: DC%2BD3sXjslGgsw%3D%3D 10.1002/art.10620 12483747 (Pubitemid 35453552)
A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6 years
10.1007/s10165-008-0116-2 18762861
H Nakahara T Mima N Yoshio-Hoshino M Matsushita J Hashimoto N Nishimoto 2009 A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6 years Mod Rheumatol 19 69 72 10.1007/s10165-008-0116-2 18762861
Glucocorticoid and cyclosporine refractory adult onset Still's disease successfully treated with tocilizumab
10.1007/s10067-009-1097-z 19184270
K Matsumoto T Nagashima S Takatori Y Kawahara M Yagi M Iwamoto, et al. 2009 Glucocorticoid and cyclosporine refractory adult onset Still's disease successfully treated with tocilizumab Clin Rheumatol 28 485 487 10.1007/s10067-009-1097-z 19184270
Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade
DOI 10.1084/jem.20050473
V Pascual F Allantaz E Arce M Punaro J Banchereau 2005 Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade J Exp Med 201 1479 1486 1:CAS:528:DC%2BD2MXktVCmurw%3D 10.1084/jem.20050473 15851489 (Pubitemid 40664091)